title: Oral Candida and Enterobacteriaceae in HIV-1 infection: correlation with clinical candidiasis and antimycotic therapy.
abstract: Oral swabs of 73 HIV-1 infected men (32 under conditions of antimycotic treatment (43.8%)) and 58 controls were cultured for Candida species and Enterobacteriaceae. In Group A without antimycotics, yeasts were isolated from 35/41 swabs (85.4%) (range 2 x 10(1) - 4 x 10(6) cfu/ml). In Group B with antimycotics, yeasts were cultured from 27/32 swabs (84.4%) (4 x 10(1) - 1 x 10(6) cfu/ml). Oral Enterobacteriaceae (o.e.) were grown from 22% of the swabs of both Group A (2 x 10(1) - 2 x 10(6) cfu/ml) and Group B (4 x 10(1) - 1.6 x 10(6) cfu/ml). Growth of o.e. and yeasts (2 x 10(3) - 4 x 10(6) cfu/ml). Correlation between yeasts and o.e. were isolated in 14% (2 x 10(1) - 6.4 x 10(6) cfu/ml). Correlation between yeasts species to local and systemic treatment deserves further investigations.
authors.affiliation: Abteilung für zahnärztliche Chirurgie/Oralchirurgie, Nord-Frie Universität, Berlin, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Schmidt-Westhausen
authors.forename: R A
authors.initials: RA
authors.lastname: Schiller
authors.forename: H D
authors.initials: HD
authors.lastname: Pohle
authors.forename: P A
authors.initials: PA
authors.lastname: Reichart
mesh_terms: D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002175:Candida / Q000145:classification / Q000302:isolation & purification*; D002180:Candidiasis, Oral / Q000150:complications* / Q000517:prevention & control; D004338:Drug Combinations; D004755:Enterobacteriaceae / Q000145:classification / Q000302:isolation & purification*; D004756:Enterobacteriaceae Infections / Q000150:complications*; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000382:microbiology*; D006679:HIV Seropositivity; D015497:HIV-1; D006801:Humans; D007654:Ketoconazole / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008825:Miconazole / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D011446:Prospective Studies; D014059:Tongue / Q000382:microbiology*
chemical_list: D000935:Antifungal Agents; D004338:Drug Combinations; D008825:Miconazole; D007654:Ketoconazole